newsfilter
← Latest News
GlobeNewswire·

Albireo to Showcase New Data at AASLD The Liver Meeting® 2022

– Seven abstracts accepted, including one oral presentation highlighting long-term data demonstrating Bylvay® (odevixibat) durable efficacy in patients with all types of PFIC – One abstract describes data on A3907, a systemic ASBT inhibitor, in d